home / stock / bhc:cc / bhc:cc news


BHC:CC News and Press, Bausch Health Companies Inc. From 08/12/25

Stock Information

Company Name: Bausch Health Companies Inc.
Stock Symbol: BHC:CC
Market: TSXC
Website: bauschhealth.com

Menu

BHC:CC BHC:CC Quote BHC:CC Short BHC:CC News BHC:CC Articles BHC:CC Message Board
Get BHC:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

BHC:CC - Why Bausch Health Stock Surged By Nearly 20%

2025-08-12 13:02:58 ET On Monday, August 11, 2025, investors accumulated shares of Bausch Health Companies ( BHC ). Within the last hour of trade, volume surged. BHC stock ended up by nearly 20% on the day on no news.... Read the full article on Seeking Alpha For further...

BHC:CC - Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners

For the Sixth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 Scholarship LAVAL, QC / ACCESS Newswire / August 7, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), tod...

BHC:CC - S&P Slips on Tariff Worries, Weak Data

The S&P 500 pulled back Tuesday as traders digested weaker-than-expected economic data and new tariff comments from President Donald Trump, stoking concerns about the state of the U.S. economy. The Dow Jones Industrial Average decreased 61.9 points to end Tuesday at 44,111.74. The bro...

BHC:CC - Bausch Health reaffirms 2025 revenue target of $4.95B-$5.1B as debt reduction and pipeline expansion advance

2025-07-30 23:31:32 ET More on Bausch Health Companies Bausch Health Companies Inc. (BHC) Q2 2025 Earnings Call Transcript Bausch Health: Repricing Potential Driven By Deleveraging Bausch Health Companies Q2 2025 Earnings Preview Bausch Health to acquire live...

BHC:CC - Bausch Health Companies Inc. (BHC) Q2 2025 Earnings Call Transcript

2025-07-30 23:30:59 ET Bausch Health Companies Inc. (BHC) Q2 2025 Earnings Conference Call July 30, 2025 05:00 PM ET Company Participants Garen Sarafian - VP & Head of Investor Relations Jean-Jacques Charhon - Executive VP & CFO Thomas J. Appio - CEO &...

BHC:CC - Bausch Health Companies GAAP EPS of $0.40 beats by $0.36, revenue of $2.53B beats by $40M

2025-07-30 16:06:41 ET Bausch Health Companies press release ( NYSE: BHC ): Q2 GAAP EPS of $0.40 beats by $0.36 . Revenue of $2.53B beats by $40M . Read the full article on Seeking Alpha For further details see: Bausch Health Companies GAAP EPS of...

BHC:CC - Bausch Health Announces Second Quarter 2025 Results

Second Quarter Consolidated Revenues of $2.53 billion, up 5% on a Reported basis and 4% on an Organic (non-GAAP) 1 basis over the prior year period GAAP Net Income Attributable to Bausch Health Companies of $148 million and GAAP Net Income of $128 million Consolidated Adjusted EBIT...

BHC:CC - Expected Canadian Company Earnings on Wednesday, July 30th, 2025

Tourmaline Oil Corp. (TOU:CA) is expected to report $0.91 for Q2 2025 Bausch Health Companies Inc. (BHC:CA) is expected to report $1.35 for Q2 2025 Information Services Corporation Class A Limited Voting Shares (ISC:CA) is expected to report for Q2 2025 Solitario Resources Corp. (SLR:...

BHC:CC - Expected earnings - Bausch Health Companies Inc.

Bausch Health Companies Inc. (BHC:CA) is expected to report $1.35 for Q2 2025

BHC:CC - Bausch Health to acquire liver drug developer Durect for $1.75 per share

2025-07-29 08:35:55 ET More on Bausch Health Companies, DURECT Bausch Health: Repricing Potential Driven By Deleveraging Bausch Health Companies Inc. (BHC) Q1 2025 Earnings Call Transcript Bausch Health Companies Inc. 2025 Q1 - Results - Earnings Call Presentation ...

Previous 10 Next 10